Perspectives on Biomarker and Surrogate Endpoint Evaluation: Discussion Forum Summary (2011)
Chapter: 9 Importance of the Biomarker Discussion Forum
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
8 Key Themes, Challenges, and Opportunities
9
Next Chapter: References
Suggested Citation:
"9 Importance of the Biomarker Discussion Forum." Institute of Medicine. 2011. Perspectives on Biomarker and Surrogate Endpoint Evaluation: Discussion Forum Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13038.
9
Importance of the Biomarker Discussion Forum
At the conclusion of the discussion forum, John R. Ball reaffirmed the committee’s goals in convening this event. He noted that the discussion forum provided an opportunity for stakeholders to learn more about the report and enabled the committee to further flesh out the rationale behind their recommendations. Importantly, the committee was also able to hear from the stakeholders affected by the report recommendations. Dr. Ball noted that these discussions were extremely valuable, and he hoped that this setting allowed all stakeholders—including industry representatives and regulators—to have a dialogue about the important issues in biomarker evaluation.
Suggested Citation:
"9 Importance of the Biomarker Discussion Forum." Institute of Medicine. 2011. Perspectives on Biomarker and Surrogate Endpoint Evaluation: Discussion Forum Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13038.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.